Ahammune Biosciences announces first-in-human studies for new vitiligo drug in partnership with Veeda Clinical Research Read more
Bayer submits application in EU for extension of finerenone to include early stages of CKD associated with type-II diabetes Read more
Enhertu improves both progression-free and overall survival in Destiny-Breast04 trial in patients with HER2-low metastatic breast cancer Read more